✦ LIBER ✦

The Role of Age on Dose-Limiting Toxicities in Phase I Dose-Escalation Trials

✍ Scribed by Schwandt, A.; Harris, P. J.; Hunsberger, S.; Deleporte, A.; Smith, G. L.; Vulih, D.; Anderson, B. D.; Ivy, S. P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A review of dose-limiting events in phas

✍ Lesley Seymour; Elizabeth Eisenhauer 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 115 KB

Phase I dose escalation trial of feverfe

✍ Eardie A. Curry; Daryl J. Murry; Christy Yoder; Karen Fife; Victoria Armstrong; 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 167 KB

Dose escalation with overdose control us

✍ Zhengjia Chen; Mourad Tighiouart; Jeanne Kowalski 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 278 KB

Adjuvant therapy in pancreatic cancer: P

✍ Aaron M. Allen; Mark M. Zalupski; John M. Robertson; Frederic E. Eckhauser; Dian 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Phase I Study to Determine the Maximal T

✍ D.M. Vail; B.D. Husbands; S.G. Kamerling; H. Simpson; I.D. Kurzman; A. McDonnell 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

Dose-finding in phase I clinical trials

✍ Ji, Y.; Li, Y.; Nebiyou Bekele, B. 📂 Article 📅 2007 🏛 SAGE Publications 🌐 English ⚖ 414 KB